Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
19n2G6Y3pzGHTL7B
Écouter
Français